108
Participants
Start Date
May 23, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Ketorolac
The experimental condition to be examined by this study is the timing of administration of ketorolac prior to IUD insertion. Ketorolac 20mg PO has proven beneficial at certain timepoints during IUD insertion in prior studies, but pharmacokinetics indicate that it could require more time until peak analgesia.
Placebo
Placebo will be used to control the timing of administration and be used to compare ketorolac to baseline standard pain control regimens
University of North Carolina - Hillsborough Campus, Hillsborough
University of North Carolina, Chapel Hill
OTHER